|
A more recent version of this article appeared on December 31, 2004
Papers In Press, published online ahead of print October 13, 2004
J. Biol. Chem, 10.1074/jbc.M408238200
Submitted on July 21, 2004
Revised on September 27, 2004
Accepted on October 13, 2004
NF-KappaB family proteins participates in multiple steps of hematopoiesis through elimination of reactive oxygen species
Soichi Nakata, Itaru Matsumura, Hirokazu Tanaka, Sachiko Ezoe, Yusuke Satoh, Jun Ishikawa, Takumi Era, and Yuzuru Kanakura
Department of Hematology and Oncology, Osaka University, Suita, Osaka 565-0879
Corresponding Author: matumura{at}bldon.med.osaka-u.ac.jp
To examine the roles for NF- B family proteins in hematopoiesis, we first expressed dominant negative Rel/NF- B (I BSR) in a factor-dependent cell line, Ba/F3. Although I BSR neither affected TPO-dependent nor gp130-mediated growth, it suppressed IL-3- and EPO-dependent growth at low concentrations. In addition, I BSR enhanced factor-deprived apoptosis through the accumulation of reactive oxygen species (ROS). When expressed in normal hematopoietic stem/progenitor cells, I BSR induced apoptosis even in the presence of appropriate cytokines by accumulating ROS. We also expressed I BSR in an inducible fashion at various stages of hematopoiesis using the OP9 system, in which hematopoietic cells are induced to develop from ES cells. When I BSR was expressed at the stage of Flk-1+ cells (putative hemangioblasts), I BSR inhibited the development of primitive hematopoietic progenitor cells by inducing apoptosis through the ROS accumulation. Furthermore, when I BSR was expressed after the development of hematopoietic progenitor cells, it inhibited their terminal differentiation towards erythrocytes, megakaryocytes, and granulocytes by inducing apoptosis through the ROS accumulation. These results indicate that NF- B is required for preventing apoptosis at multiple steps of hematopoiesis by eliminating ROS.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Satoh, I. Matsumura, H. Tanaka, S. Ezoe, K. Fukushima, M. Tokunaga, M. Yasumi, H. Shibayama, M. Mizuki, T. Era, et al.
AML1/RUNX1 Works as a Negative Regulator of c-Mpl in Hematopoietic Stem Cells
J. Biol. Chem.,
October 31, 2008;
283(44):
30045 - 30056.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Erusalimsky and S. Moncada
Nitric Oxide and Mitochondrial Signaling: From Physiology to Pathophysiology
Arterioscler. Thromb. Vasc. Biol.,
December 1, 2007;
27(12):
2524 - 2531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Naujokat and T. Saric
Concise Review: Role and Function of the Ubiquitin-Proteasome System in Mammalian Stem and Progenitor Cells
Stem Cells,
October 1, 2007;
25(10):
2408 - 2418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Cilloni, G. Martinelli, F. Messa, M. Baccarani, and G. Saglio
Nuclear factor {kappa}B as a target for new drug development in myeloid malignancies
Haematologica,
September 1, 2007;
92(9):
1224 - 1229.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Panepucci, R. T. Calado, V. Rocha, R. Proto-Siqueira, W. A. Silva Jr., and M. A. Zago
Higher Expression of Transcription Targets and Components of the Nuclear Factor-{kappa}B Pathway Is a Distinctive Feature of Umbilical Cord Blood CD34+ Precursors
Stem Cells,
January 1, 2007;
25(1):
189 - 196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Um and H. F. Lodish
Antiapoptotic Effects of Erythropoietin in Differentiated Neuroblastoma SH-SY5Y Cells Require Activation of Both the STAT5 and AKT Signaling Pathways
J. Biol. Chem.,
March 3, 2006;
281(9):
5648 - 5656.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|